X-linked Dystonia-Parkinsonism (XDP) is a progressive neurodegenerative disease involving the loss of medium spiny neurons within the striatum. An XDP-specific haplotype has been identified, consisting of seven sequence variants which cluster around the human TAF1 gene, but a direct relationship between any of these variants and disease pathogenesis has not yet been demonstrated. Because the pathogenic gene lesion remains unclear, it has been difficult to predict cellular pathways which are affected in XDP cells. To address that issue, we assayed expression of defined gene sets in XDP vs. control fibroblasts to identify networks of functionally-related transcripts which may be dysregulated in XDP patient cells. That analysis derived a 51-gene signature distinguishing XDP vs. control fibroblasts which mapped strongly to nuclear factor-kappa B (NFκB), a transcription factor pathway also implicated in the pathogenesis of other neurodegenerative diseases, including Parkinson's (PD) and Huntington's disease (HD). Constitutive and TNFα-evoked NFκB signaling was further evaluated in XDP vs. control fibroblasts based on luciferase reporter activity, DNA binding of NFκB subunits, and endogenous target gene transcription. Compared to control cells, XDP fibroblasts exhibited decreased basal NFκB activity and decreased levels of the active NFκB p50 subunit, but increased target gene expression in response to TNFα. NFκB signaling was further examined in neural stem cells differentiated from XDP and control induced pluripotent stem cell (iPSC) lines, revealing a similar pattern of increased TNFα responses in the patient lines compared to controls. These data indicate that an NFκB signaling phenotype is present in both patient fibroblasts and neural stem cells, suggesting this pathway as a site of dysfunction in XDP.
Introduction
X-Linked Dystonia-Parkinsonism (XDP) is a rare neurodegenerative disease characterized by adult-onset, progressive dystonia which over time is combined with or replaced by features of parkinsonism (Evidente et al., 2002a; Evidente et al., 2002b; Lee et al., 1991; Lee et al., 2002; Lee et al., 2011) . The disease has been associated with the loss of medium spiny neurons within the striatum (Goto et al., 2013; Goto et al., 2005) , although the involvement of other brain regions has not been definitively excluded, and the mechanisms underlying XDP neuropathology are not known. XDP primarily affects men from the island of Panay, Philippines, where the reported disease prevalence is approximately 5.74 cases per 100,000 individuals (Lee et al., 2011) . It has been hypothesized that the disorder arises due to a founder mutation in this population, but identifying the pathogenic gene variant has proven difficult. Genetic studies over many years have culminated in the discovery of an XDP-specific haplotype consisting of seven sequence variants which affected individuals appear to inherit in a consistent "all or none" fashion (Domingo et al., 2015; Graeber and Muller, 1992;  Neurobiology of Disease 100 (2017) 108-118
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